Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | CVS | TMO |
|---|
| Close | 91.72 | 648.43 |
| Market Cap | $117B | $240B |
| 1M | −2.44% | +10.75% |
| P/E (TTM) | 24.4 | 34.4 |
| Forward P/E | 13.2 | 21.8 |
| P/E 5-Yr Percentile | 65 | 65 |
| P/S | 0.3 | 5.2 |
| P/B | 1.5 | 4.6 |
| Dividend Yield | 3.49% | 0.29% |
| Latest Quarter Revenue | $106B | $12.0B |
| Revenue YoY | +7.3% | +10.5% |
| Gross Margin | 44.5% | — |
| Latest Quarter EPS | 2.31 | 4.68 |
| Avg Post-Earnings Move | ±2.3% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 2.36% |
| 90-Day Net Insider Buying | — | −$38.9M |
CVS · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
